or Try an Advanced Search...

    Technical Analysis for ATAI - ATAI Life Sciences N.V.

    Grade Last Price % Change Price Change
    D 1.86 -9.27% -0.19
    ATAI closed down 9.27 percent on Thursday, May 16, 2024, on 89 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical ATAI trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    Fell Below 50 DMA Bearish 0.00%
    180 Bearish Setup Bearish Swing Setup 0.00%
    Inside Day Range Contraction 0.00%
    Crossed Above 20 DMA Bullish -9.27%
    Crossed Above 50 DMA Bullish -9.27%
    180 Bullish Setup Bullish Swing Setup -9.27%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -9.27%
    Pocket Pivot Bullish Swing Setup -9.27%
    BB Squeeze Ended Range Expansion -9.27%
    Older End-of-Day Signals for ATAI ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 6 hours ago
    60 Minute Opening Range Breakdown about 9 hours ago
    Down 5% about 10 hours ago
    Fell Below 20 DMA about 10 hours ago
    20 DMA Support about 10 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ATAI Chart by TradingView
    Basic chart:

    Profile

    atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape, as well as the emergence of therapies that previously may have been overlooked or underused, including psychedelic compounds and digital therapeutics. atai is headquartered in Berlin, with offices in New York and London.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Medication Disability Mental Health Psychiatry Mental Disorder Positive Psychology Mental Health Disorders

    Is ATAI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 ATAI Life Sciences GAAP EPS of -$0.17 beats by $0.01
    May 15 atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates
    Apr 29 Psychedelic drug developers could benefit from NIH funding for chronic pain
    Apr 24 atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
    Apr 17 atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
    Apr 3 Atai Life Sciences upgraded at Maxim on Beckley investment
    Apr 1 Atai Life Sciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
    Mar 28 ATAI Life Sciences GAAP EPS of -$0.12 beats by $0.04
    Mar 28 atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
    Mar 27 atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant Depression
    See more ATAI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.85
    52 Week Low 1.025
    Average Volume 1,671,009
    200-Day Moving Average 1.63
    50-Day Moving Average 2.00
    20-Day Moving Average 1.97
    10-Day Moving Average 1.99
    Average True Range 0.17
    RSI (14) 44.13
    ADX 18.3
    +DI 19.81
    -DI 13.90
    Chandelier Exit (Long, 3 ATRs) 1.78
    Chandelier Exit (Short, 3 ATRs) 2.30
    Upper Bollinger Bands 2.15
    Lower Bollinger Band 1.79
    Percent B (%b) 0.19
    BandWidth 18.04
    MACD Line -0.02
    MACD Signal Line -0.01
    MACD Histogram -0.0124
    Fundamentals Value
    Market Cap 308.78 Million
    Num Shares 166 Million
    EPS -0.43
    Price-to-Earnings (P/E) Ratio -4.33
    Price-to-Sales 859.87
    Price-to-Book 1.09
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.16
    Resistance 3 (R3) 2.19 2.13 2.11
    Resistance 2 (R2) 2.13 2.05 2.11 2.09
    Resistance 1 (R1) 1.99 2.00 1.96 1.96 2.08
    Pivot Point 1.93 1.93 1.91 1.91 1.93
    Support 1 (S1) 1.79 1.85 1.76 1.76 1.64
    Support 2 (S2) 1.73 1.80 1.71 1.63
    Support 3 (S3) 1.59 1.73 1.61
    Support 4 (S4) 1.56